» Articles » PMID: 12707343

A Role of CXC Chemokine Ligand 12/stromal Cell-derived Factor-1/pre-B Cell Growth Stimulating Factor and Its Receptor CXCR4 in Fetal and Adult T Cell Development in Vivo

Overview
Journal J Immunol
Date 2003 Apr 23
PMID 12707343
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The functions of a chemokine CXC chemokine ligand (CXCL) 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its physiologic receptor CXCR4 in T cell development are controversial. In this study, we have genetically further characterized their roles in fetal and adult T cell development using mutant and chimeric mice. In CXCL12(-/-) or CXCR4(-/-) embryos on a C57BL/6 background, accumulation of T cell progenitors in the outer mesenchymal layer of the thymus anlage during initial colonization of the fetal thymus was comparable with that seen in wild-type embryos. However, the expansion of CD3(-)CD4(-)CD8(-) triple-negative T cell precursors at the CD44(-)CD25(+) and CD44(-)CD25(-) stages, and CD4(+)CD8(+) double-positive thymocytes was affected during embryogenesis in these mutants. In radiation chimeras competitively repopulated with CXCR4(-/-) fetal liver cells, the reduction in donor-derived thymocytes compared with wild-type chimeras was much more severe than the reduction in donor-derived myeloid lineage cells in bone marrow. Triple negative CD44(+)CD25(+) T cell precursors exhibited survival response to CXCL12 in the presence of stem cell factor as well as migratory response to CXCL12. Thus, it may be that CXCL12 and CXCR4 are involved in the expansion of T cell precursors in both fetal and adult thymus in vivo. Finally, enforced expression of bcl-2 did not rescue impaired T cell development in CXCR4(-/-) embryos or impaired reconstitution of CXCR4(-/-) thymocytes in competitively repopulated mice, suggesting that defects in T cell development caused by CXCR4 mutation are not caused by reduced expression of bcl-2.

Citing Articles

Vhl safeguards thymic epithelial cell identity and thymopoietic capacity by constraining Hif1a activity during development.

Grammer C, Komorowska J, Swann J iScience. 2024; 27(7):110258.

PMID: 39040069 PMC: 11261450. DOI: 10.1016/j.isci.2024.110258.


Optimizing in vitro T cell differentiation by using induced pluripotent stem cells with GFP-RUNX1 and mCherry-TCF7 labelling.

Zhao Y, Cao J, Xu H, Cao W, Cheng C, Tan S Cell Prolif. 2024; 57(10):e13661.

PMID: 38853761 PMC: 11471423. DOI: 10.1111/cpr.13661.


Utilization of next-generation sequencing to define the role of heterozygous variants in immunodeficiency.

Pasternak Y, Vong L, Merico D, Abrego Fuentes L, Scott O, Sham M J Allergy Clin Immunol Glob. 2024; 3(3):100267.

PMID: 38800615 PMC: 11127205. DOI: 10.1016/j.jacig.2024.100267.


Single-Cell RNA-Sequencing Reveals the Skeletal Cellular Dynamics in Bone Repair and Osteoporosis.

Wu S, Ohba S, Matsushita Y Int J Mol Sci. 2023; 24(12).

PMID: 37372962 PMC: 10298577. DOI: 10.3390/ijms24129814.


Age-associated declining of the regeneration potential of skeletal stem/progenitor cells.

Mancinelli L, Intini G Front Physiol. 2023; 14:1087254.

PMID: 36818437 PMC: 9931727. DOI: 10.3389/fphys.2023.1087254.